Livzon Pharmaceutical Group(HK:1513)
HK$24.62-0.10 (-0.40%)
HK:1513
Livzon Pharmaceutical Group Revenue
HK$24.62
At close:-0.10 (-0.40%)
Want to see HK:1513 full AI Analyst Report?
Livzon Pharmaceutical Group (1513) Revenue
1 Followers
Livzon Pharmaceutical Group Revenue
Livzon Pharmaceutical Group had a revenue of 2.32B in the quarter ending Sep 30, 2026, with 9.42%. This bring the company's revenue in the last twelve months to 10.17B, Decreased 4.90%. In the fiscal year ending Dec 31, 2025, Livzon Pharmaceutical Group had annual revenue of 12.02B with 1.76% growth.
- Revenue (ttm)
- 10.17B
- Revenue Growth
- -9.56%
- P/S Ratio
- 2.42
- Revenue/Employee
- HKD 1,353,948
- Employees
- 8,878
- Market Cap
- HKD 29.06B
Revenue Chart
Livzon Pharmaceutical Group Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.02B | 208.01M | 1.76% |
| Dec 31, 2024 | 11.81B | -617.70M | -4.97% |
| Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
| Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
| Dec 31, 2021 | 12.06B | 1.54B | 14.67% |
| Dec 31, 2020 | 10.52B | 1.14B | 12.10% |
| Dec 31, 2019 | 9.38B | 524.04M | 5.91% |
| Dec 31, 2018 | 8.86B | 329.69M | 3.86% |
| Dec 31, 2017 | 8.53B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.